The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Citalopram (Citalop Tab (10 mg)) is a selective ...

Medically reviewed by Patricia Mikula, PharmD Key Takeaways Celexa and Lexapro are both SSRIs used to treat ...

Citalopram (Citalomine (10 mg)) is a selective serotonin reuptake inhibitor (SSRI), prescribed for depression. It works by increasing the amount of serotonin, a natural substance in the brain that ...

Enhancement of serotonin neurotransmission plays an important role in the antidepressant response to agents presently available to treat depression. This response forms the major evidence for the role ...

The antidepressants, reboxetine and citalopram, were used in conjunction with voluntary physical exercise (wheel running) in order to assess the contribution of noradrenergic and serotonergic ...

Although no medications are currently approved by the US Food and Drug Administration for core symptoms of autism spectrum disorders (ASDs), selective serotonin reuptake inhibitors are widely ...

Up to 75% of women experience hot flashes, which can negatively impact quality of life. As hot flash physiology is not definitively understood, it cannot be assumed that effective agents represent ...

PEAPACK, N.J.--(BUSINESS WIRE)-- Greenstone LLC announced today that it is voluntarily conducting a recall, to the patient level, of medicines with lot number FI0510058-A on the label. This includes ...

A 15-year-old female with MD and panic disorder was placed on paroxetine 10 mg for 5 days, then 20 mg. She reported an abrupt increase in suicidal ideation, new marked anxiety and insomnia, and ...

Greenstone announced a recall of medicines labeled with the Lot # FI0510058-A because they may be mislabeled. Bottles labeled as containing citalopram may contain finasteride. This recall includes 100 ...

Hyderabad: Pfizer recalled Citalopram tablets, manufactured by city-based Aurobindo Pharma, from the US market owing to wrong labelling, the pharma major has said in a filing with the US health ...